Ryan J Brisson

5PUBLICATIONS
7CO-AUTHORS
Groundwater quality processes and contaminated land assessmentCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 17, 2023
The ruse of reduction - comment to Zeng et al.

Vincent Cassidy, Ryan J Brisson

|May 10, 2021
The role of chemotherapy in the management of olfactory neuroblastoma: A 40-year surveillance, epidemiology, and end results registry study.

Ryan J Brisson, Thomas J Quinn, Rohan L Deraniyagala

|May 05, 2020
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.

Tanguy Y Seiwert, Sara Kochanny, Kevin Wood

|Feb 20, 2020
A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.

Sara E Kochanny, Francis P Worden, Douglas R Adkins

|Sep 06, 2019
A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer.

Ryan J Brisson, Sara Kochanny, Saba Arshad

Pageof 1

Frequent Collaborators

2 joint publications

Sara Kochanny

2 joint publications

Walter M Stadler

2 joint publications

Everett E Vokes

2 joint publications

Tanguy Y Seiwert